Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.23.1
Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series E-1 Preferred Stock [Member]
Common Stock [Member]
Deferred Stock Based Compensation [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 2 $ 165 $ (900,742) $ 29,765,585 $ (29,281,674) $ (416,664)
Beginning Balance, shares at Dec. 31, 2021 1,509 1,652,102        
Common stock issued for services $ 3 254,748 254,751
Common stock issused for services, shares     28,750        
Conversion of debentures $ 1 34,999 35,000
Conversion of debentures, shares     5,469        
Incremental value from warrant modifications 41,225 (41,225)
Series A, preferred stock contractual dividends (7,202) (7,202)
40:1 Reverse Split Fractional Shares Adjustment
40:1 Reverse Split Fractional Shares Adjustment, shares     266        
Series B, preferred stock contractual dividends (37,206) (37,206)
Accretion of stock-based compensation to employees and directors 213,041 107,312 320,353
Net loss period (1,788,246) (1,788,246)
Ending balance, value at Mar. 31, 2022 $ 2 $ 169 (687,701) 30,159,461 (31,111,145) (1,639,214)
Ending balance, shares at Mar. 31, 2022 1,509 1,686,587        
Beginning balance, value at Dec. 31, 2022 $ 2 $ 228 (187,329) 33,428,115 (35,177,625) (1,936,609)
Beginning Balance, shares at Dec. 31, 2022 1,509 2,279,019        
Common stock issued for services $ 2 115,090 141,477 256,569
Common stock issused for services, shares     16,500        
Incremental value from warrant modifications 282,309 (282,309)
Series A, preferred stock contractual dividends (7,200) (7,200)
Series B, preferred stock contractual dividends (37,207) (37,207)
Accretion of stock-based compensation to employees and directors 36,740 132,593 169,333
Net loss period (1,507,042) (1,507,042)
Deemed dividend from Series A conversion price adjustment 96,245 (96,245)
Deemed dividend from Series B conversion price adjustment 168,835 (168,835)
Issuance of common stock for cash $ 7 314,239 314,246
Issuance of common stock for cash, shares     69,834        
Exercise of warrants for cash to common stock $ 37 1,094,965 1,095,001
Exercise of warrants for cash to common stock, shares     365,001        
Conversion of convertible debt to common stock $ 16 519,696 519,712
Conversion of convertible debt to common stock, shares     164,446        
Inducement for conversion of convertible debt 397,937 397,937
Ending balance, value at Mar. 31, 2023 $ 2 $ 290 $ (35,499) $ 36,532,003 $ (37,232,056) $ (735,260)
Ending balance, shares at Mar. 31, 2023 1,509 2,894,800